Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital) - Global Forecast to 202

Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital) - Global Forecast to 2023

“Rising prevalence for chronic diseases and growth in the biologics market are expected to drive the overall growth of the pharmaceutical drug delivery market.”
The global pharmaceutical drug delivery market is projected to reach USD 1,694.7 billion by 2023 from USD 1,244.4 billion in 2018, at a CAGR of 6.4% during the forecast period. Growth in this market is mainly driven by the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements and new product launches. On the other hand, the risk of needlestick injuries and the increasing pricing pressure are expected to challenge market growth in the coming years.

“The home care settings segment is expected to grow at the highest CAGR during the forecast period.”
Based on facility of use, the pharmaceutical drug delivery market is segmented hospitals, ambulatory surgical centers (ASCs)/clinics, diagnostic centers, home care settings, and other facilities of use. The home care settings segment is expected to grow at a higher CAGR during the forecast period. This can majorly be attributed to increasing use of various drug delivery devices such as injectables, nebulizers, and inhalers in home care settings.

“The conventional injection devices segment accounted for the largest share of the injectable drug delivery market in 2018.”
Based on type, the injectable drug delivery technology is segmented into conventional injection devices, self-injection devices, and other devices. In 2018, conventional injection devices accounted for the largest share of the injectable drug delivery technology market. The large share of this segment can primarily be attributed to factors such as the low cost of devices and manufacturing, large molecular size of biologics administered through injectables, and the widespread popularity of conventional devices.

“North America to dominate the market during the forecast period.”
In 2018, North America accounted for the largest share of the pharmaceutical drug delivery market. The large share of the North American market is due to factors such as the rising prevalence of chronic diseases such as cancer, respiratory allergies, and diabetes; growth in biologics in the pharmaceuticals market; and the presence of a large number of prominent players in this region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 (55%), Tier 2 (25%), and Tier 3 (20%)
• By Designation: C-level (43%), D-level (32%), and Others (25%)
• By Region: North America (38%), Europe (23%), Asia (29%), and RoW (10%)

List of Companies Profiled in the Report
• Johnson & Johnson, Inc. (US)
• F. Hoffman-La Roche (Switzerland)
• Merck & Co., Inc. (US)
• Bayer AG (Germany)
• Pfizer, Inc. (US)
• Novartis AG (Switzerland)
• 3M Company (US)
• Becton, Dickinson and Company (US)
• GlaxoSmithKline plc, (UK)
• Sanofi (France)
• Antares Pharma, Inc. (US).

Research Coverage:
This report provides a detailed picture of the global pharmaceutical drug delivery market. It aims at estimating the size and future growth potential of the market across different segments, such as route of administration, application, facility of use, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical drug delivery market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.